- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 191.59M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$51.11M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$73.21M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $204.59M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $84.02M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $93.54M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $642.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $567.06M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $721.08M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $777.79M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $29.75M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $25.58M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $57.43M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $54.27M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $658.46M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $578.28M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $699.61M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $621.33M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.41 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.46 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.41 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.46 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $11.03M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $18.74M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$73.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$77.07M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$78.59M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$84.87M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3M |
| Revenue | Q1 2026 · Mar 31, 2025 | $7.68M |
| Capex | Q1 2026 · Mar 31, 2025 | $384K |